NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Amphastar Wins FDA Approval for Affordable Osteoporosis Treatment

Amphastar Pharmaceuticals receives FDA approval for generic teriparatide injection, offering an affordable alternative to Eli Lilly's FORTEO for osteoporosis patients.

Amphastar Wins FDA Approval for Affordable Osteoporosis Treatment
Photo by Danielle Barnes on Unsplash
Already have an account? Sign in.
12/15/2025 · 11:34 AM
AMPH
/ Read more

Feed↓

Rosenblatt Calls CoreWeave the “De Facto Operating System for AI” with Buy Rating and 148% Upside
06/25/2026 · 7:11 AM

Rosenblatt Calls CoreWeave the “De Facto Operating System for AI” with Buy Rating and 148% Upside

Nearly 50 data centers, $100B backlog, and 77% expected annual growth through 2030.

/ Subscriber only
ARS Pharmaceuticals Shares Plunge as Neffy Misses July Insurance Wins
06/25/2026 · 6:54 AM

ARS Pharmaceuticals Shares Plunge as Neffy Misses July Insurance Wins

Despite the setback, Florida Medicaid coverage begins July 1, the company cut 2026 expenses to $248M, and it remains on track for cash-flow breakeven in 2027.

/ Subscriber only
Merck Bolsters Life Sciences Portfolio with $11.3B Bio-Techne Acquisition
Featured/ 06/25/2026 · 6:32 AM

Merck KGaA Bolsters Life Sciences Portfolio with $11.3B Bio-Techne Acquisition

Acquisition of a medical tools maker will be the German group’s biggest in over a decade.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe